• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于双基因的风险评分可预测有酒精摄入风险的男性发生酒精性肝硬化的情况。

A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption.

作者信息

Mancina Rosellina Margherita, Ferri Flaminia, Farcomeni Alessio, Molinaro Antonio, Maffongelli Angela, Mischitelli Monica, Poli Edoardo, Parlati Lucia, Burza Maria Antonella, De Santis Adriano, Attilia Fabio, Rotondo Claudia, Rando Maria Margherita, Attilia Maria Luisa, Ceccanti Mauro, Ginanni Corradini Stefano

机构信息

Department of Molecular and Clinical Medicine, The Sahlgrenska Academy at the University of Gothenburg, Wallenberg Laboratory, Göteborg, Sweden,

Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy,

出版信息

Appl Clin Genet. 2019 Jan 10;12:1-10. doi: 10.2147/TACG.S187922. eCollection 2019.

DOI:10.2147/TACG.S187922
PMID:30666147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6330982/
Abstract

BACKGROUND

Alcoholic cirrhosis represents 1% of all cause-of-deaths worldwide. Its incidence is higher in males and results from the combination of environmental and genetic factors. Among all the genetic determinants of alcoholic cirrhosis, the patatin-like phospholipase domain protein 3 () rs738409 represents the most widely validated determinant. Recent cross-sectional studies on alcohol abusers identified transmembrane-6 superfamily member 2 () rs58542926, membrane bound O-acyltransferase domain containing 7 () rs641738, and cluster of differentiation 14 () rs2569190 as new genetic risk factors for alcoholic cirrhosis. We aimed to develop a gene-based risk score to predict the incidence of alcoholic cirrhosis in males with at-risk alcohol consumption.

MATERIALS AND METHODS

A total of 416 male at-risk alcohol drinkers were retrospectively examined. The association between alcoholic cirrhosis incidence and , , , and variants was tested. Age at onset of at-risk alcohol consumption, age, and body mass index (BMI) were included as covariates to determine the prediction score for alcoholic cirrhosis incidence by evaluating time-dependent receiver operating characteristic curves.

RESULTS

We found that , , and were associated with alcoholic cirrhosis prevalence. and were also associated with its incidence. The best predictive score formula was (age at onset of at-risk alcohol consumption × 0.1) + (number of allele T) + (number of allele M) + (BMI × 0.1). A threshold of 7.27 was identified as cutoff for the predictive risk of alcoholic cirrhosis development in 36 years from the onset of at-risk alcohol consumption with 70.1% sensitivity and 78.7% specificity.

CONCLUSION

We developed the first score for alcoholic cirrhosis prediction that combines clinical and genetic factors.

摘要

背景

酒精性肝硬化占全球所有死因的1%。其发病率在男性中更高,是环境和遗传因素共同作用的结果。在酒精性肝硬化的所有遗传决定因素中,类Patatin磷脂酶结构域蛋白3()rs738409是最广泛验证的决定因素。最近对酗酒者的横断面研究确定跨膜6超家族成员2()rs58542926、含膜结合O-酰基转移酶结构域7()rs641738和分化簇14()rs2569190为酒精性肝硬化的新遗传风险因素。我们旨在开发一种基于基因的风险评分,以预测有饮酒风险的男性患酒精性肝硬化的发生率。

材料与方法

对416名有饮酒风险的男性进行回顾性检查。测试酒精性肝硬化发病率与、、和变异之间的关联。将有饮酒风险开始时的年龄、年龄和体重指数(BMI)作为协变量,通过评估时间依赖性受试者工作特征曲线来确定酒精性肝硬化发病率的预测评分。

结果

我们发现、和与酒精性肝硬化患病率相关。和也与其发病率相关。最佳预测评分公式为(有饮酒风险开始时的年龄×0.1)+(等位基因T的数量)+(等位基因M的数量)+(BMI×0.1)。确定7.27为从有饮酒风险开始36年内酒精性肝硬化发生预测风险的临界值,敏感性为70.1%,特异性为78.7%。

结论

我们开发了首个结合临床和遗传因素的酒精性肝硬化预测评分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ecb/6330982/a3c7e8917ff0/tacg-12-001Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ecb/6330982/a3c7e8917ff0/tacg-12-001Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ecb/6330982/a3c7e8917ff0/tacg-12-001Fig1.jpg

相似文献

1
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption.一种基于双基因的风险评分可预测有酒精摄入风险的男性发生酒精性肝硬化的情况。
Appl Clin Genet. 2019 Jan 10;12:1-10. doi: 10.2147/TACG.S187922. eCollection 2019.
2
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.载脂蛋白基因变异与 TM6SF2 基因变异易导致酒精性肝硬化患者发生肝细胞癌。
Am J Gastroenterol. 2018 Oct;113(10):1475-1483. doi: 10.1038/s41395-018-0041-8. Epub 2018 Mar 13.
3
A study of genetic variants, genetic risk score and DNA methylation of PNPLA3 and TM6SF2 in alcohol liver cirrhosis.酒精性肝硬化中PNPLA3和TM6SF2的基因变异、遗传风险评分及DNA甲基化研究
Indian J Gastroenterol. 2023 Dec;42(6):800-807. doi: 10.1007/s12664-023-01420-1. Epub 2023 Aug 17.
4
PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.PNPLA3 I148M(rs738409)基因变异与高危饮酒起始年龄是酒精性肝硬化的独立危险因素。
Liver Int. 2014 Apr;34(4):514-20. doi: 10.1111/liv.12310. Epub 2013 Sep 19.
5
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History.基于遗传易感性和饮酒史的酒精性肝硬化发展的新诊断和预后模型
Biomedicines. 2023 Jul 28;11(8):2132. doi: 10.3390/biomedicines11082132.
6
PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis.PNPLA3基因rs738409位点和TM6SF2基因rs58542926位点的变异增加了酒精性肝硬化患者患肝细胞癌的风险。
Dig Liver Dis. 2016 Jan;48(1):69-75. doi: 10.1016/j.dld.2015.09.009. Epub 2015 Sep 28.
7
Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis.候选基因变异在调节酒精性肝炎的风险和严重程度中的作用。
Alcohol Clin Exp Res. 2021 Apr;45(4):709-719. doi: 10.1111/acer.14581. Epub 2021 Apr 20.
8
The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.膜结合 O-酰基转移酶 7 rs641738 变异与儿童非酒精性脂肪性肝病。
J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):69-74. doi: 10.1097/MPG.0000000000001979.
9
[Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].[PNPLA3、TM6SF2基因多态性及其与吸烟和饮酒的相互作用对乙型肝炎病毒相关肝细胞癌的影响]
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Dec 10;39(12):1611-1616. doi: 10.3760/cma.j.issn.0254-6450.2018.12.014.
10
and Gene Variants in Liver Fibrosis and Cirrhosis.以及肝纤维化和肝硬化中的基因变异。
Int J Mol Sci. 2019 Mar 14;20(6):1277. doi: 10.3390/ijms20061277.

引用本文的文献

1
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History.基于遗传易感性和饮酒史的酒精性肝硬化发展的新诊断和预后模型
Biomedicines. 2023 Jul 28;11(8):2132. doi: 10.3390/biomedicines11082132.
2
A study of genetic variants, genetic risk score and DNA methylation of PNPLA3 and TM6SF2 in alcohol liver cirrhosis.酒精性肝硬化中PNPLA3和TM6SF2的基因变异、遗传风险评分及DNA甲基化研究
Indian J Gastroenterol. 2023 Dec;42(6):800-807. doi: 10.1007/s12664-023-01420-1. Epub 2023 Aug 17.
3
Pattern recognition receptor CD14 gene polymorphisms in alcohol use disorder patients and its Influence on liver disease susceptibility.

本文引用的文献

1
Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males.单核苷酸 rs738409 多态性与汉族男性酒精性肝病密切相关。
Hepatol Int. 2018 Sep;12(5):429-437. doi: 10.1007/s12072-018-9889-3. Epub 2018 Aug 21.
2
The high burden of alcoholic cirrhosis in privately insured persons in the United States.美国私人保险人群中酒精性肝硬化的高负担。
Hepatology. 2018 Sep;68(3):872-882. doi: 10.1002/hep.29887. Epub 2018 May 20.
3
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.
酒精使用障碍患者模式识别受体 CD14 基因多态性及其对肝病易感性的影响。
Front Immunol. 2022 Sep 27;13:975027. doi: 10.3389/fimmu.2022.975027. eCollection 2022.
4
Epigenetics of alcohol-related liver diseases.酒精性肝病的表观遗传学
JHEP Rep. 2022 Mar 10;4(5):100466. doi: 10.1016/j.jhepr.2022.100466. eCollection 2022 May.
5
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.酒精性肝病:基础机制与临床视角。
Int J Mol Sci. 2021 May 13;22(10):5170. doi: 10.3390/ijms22105170.
6
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets.非酒精性脂肪性肝炎(NASH)与酒精性脂肪性肝炎(ASH)之间的遗传易感性相似性:新治疗靶点的鉴定
JHEP Rep. 2021 Mar 30;3(3):100284. doi: 10.1016/j.jhepr.2021.100284. eCollection 2021 Jun.
7
Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).遗传和表观遗传疾病修饰因子:非酒精性脂肪性肝病(NAFLD)和酒精性肝病(ALD)。
Transl Gastroenterol Hepatol. 2021 Jan 5;6:2. doi: 10.21037/tgh.2019.09.06. eCollection 2021.
8
Restricted immunological and cellular pathways are shared by murine models of chronic alcohol consumption.慢性酒精摄入的小鼠模型存在受限的免疫和细胞通路。
Sci Rep. 2020 Feb 12;10(1):2451. doi: 10.1038/s41598-020-59188-9.
一种截短蛋白的HSD17B13变体与慢性肝病的防护
N Engl J Med. 2018 Mar 22;378(12):1096-1106. doi: 10.1056/NEJMoa1712191.
4
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.载脂蛋白基因变异与 TM6SF2 基因变异易导致酒精性肝硬化患者发生肝细胞癌。
Am J Gastroenterol. 2018 Oct;113(10):1475-1483. doi: 10.1038/s41395-018-0041-8. Epub 2018 Mar 13.
5
Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening.肝脏疾病:一个严重且被忽视的全球公共卫生问题,需要紧急行动和大规模筛查。
Liver Int. 2018 Feb;38 Suppl 1:2-6. doi: 10.1111/liv.13682.
6
Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease.体重指数升高是与不同病因慢性肝病相关的可能发生肝硬化的一个危险因素。
J Formos Med Assoc. 2018 Apr;117(4):268-275. doi: 10.1016/j.jfma.2017.09.002. Epub 2017 Sep 22.
7
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.MBOAT7 rs641738 变异与非肝硬化个体的肝细胞癌。
Sci Rep. 2017 Jul 3;7(1):4492. doi: 10.1038/s41598-017-04991-0.
8
Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program.入住酒精治疗项目的男性和女性酒精依赖个体的肝损伤和内毒素血症
Alcohol Clin Exp Res. 2017 Apr;41(4):747-757. doi: 10.1111/acer.13346. Epub 2017 Mar 2.
9
Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the variant I148M.携带I148M变异的重度饮酒者在酒精戒断后出现原发性肝损伤及肝脏硬度延迟恢复。
World J Hepatol. 2016 Dec 18;8(35):1547-1556. doi: 10.4254/wjh.v8.i35.1547.
10
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.TM6SF2基因的rs58542926位点影响肝脏和小肠中的脂质代谢过程。
Hepatology. 2017 May;65(5):1526-1542. doi: 10.1002/hep.29021. Epub 2017 Mar 22.